Leerink Partners LLC named Marc Goodman as managing director and senior research analyst for its therapeutics team, under equity research.
Goodman will be assigned to the company's New York office. He was previously a managing director and U.S. healthcare analyst, with a focus on large-cap and specialty pharmaceuticals sectors, at UBS Investment Bank.
